Your browser doesn't support javascript.
loading
Favorable response to mammalian target of rapamycin inhibition in a young patient with unresectable fibrolamellar carcinoma of the liver.
Bill, Ruben; Montani, Matteo; Blum, Benedikt; Dufour, Jean-François; Escher, Robert; Bühlmann, Michael.
Afiliação
  • Bill R; Department of Internal Medicine, Spital Emmental, Burgdorf, Switzerland.
  • Montani M; Institute of Pathology, University of Bern, Bern, Switzerland.
  • Blum B; Department of Radiology, Spital Emmental, Burgdorf, Switzerland.
  • Dufour JF; Hepatology Unit, Department of Clinical Research, University Hospital Bern, Bern, Switzerland.
  • Escher R; Department of Internal Medicine, Spital Emmental, Burgdorf, Switzerland.
  • Bühlmann M; Department of Internal Medicine, Spital Emmental, Burgdorf, Switzerland.
Hepatology ; 68(1): 384-386, 2018 07.
Article em En | MEDLINE | ID: mdl-29473972
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Everolimo / Neoplasias Hepáticas / Antineoplásicos Limite: Adult / Humans / Male Idioma: En Revista: Hepatology Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Everolimo / Neoplasias Hepáticas / Antineoplásicos Limite: Adult / Humans / Male Idioma: En Revista: Hepatology Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suíça